. EN
Indetek Lab commits to the business model of "in-house development + external cooperation" and continues to optimize its pipelines through self-development, in/out licensing and co-development and any other business models.
  • 01.

    Commercialize existing pipelines domestically through flexible business models

  • 02.

    Introduce innovative transdermal technology platforms through licensing or co-development, and continue to optimize the company's pipelines

  • 03.

    Seeking out-licensing and co-development opportunities for its ILDS® platform

Please email to:BD@indetek-lab.com

We will respond to your request in a timely manner.